MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-PB-20-0038188
Ace Medipharma Private Limited
Ace Medipharma Private Limited - pharma in Ambala Cantt, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.17 Cr
▲ 4% YoY
Net profit · FY 2024
₹68,890
Net margin 0.3%
EBITDA · FY 2024
₹3.37 Lakh
EBITDA margin 1.6%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹40 Lakh
Secured borrowings
Company age
17 yrs
Est. 2009
Directors on board
2
As per MCA filings
About Ace Medipharma Private Limited
Data last updated:
Ace Medipharma Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 May 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24296HR2009PTC039075. Its GSTIN is 03AAHCA7582R1Z1 (Punjab).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Narender Pal Singh and Paramjot Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 – A Gobind Nagar Near Gurudwara, Ambala Cantt, Haryana, India – 133001.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.17 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹68,890 (net margin 0.3%) and EBITDA of ₹3.37 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹40 Lakh on record.
Ace Medipharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0038188). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Ace Medipharma Private Limited
CIN U24296HR2009PTC039075
Registration Number 039075
Incorporation Date 11 May 2009
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-PB-20-0038188
Recognitions & Rankings of Ace Medipharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address3 – A Gobind Nagar Near Gurudwara, Ambala Cantt, Haryana, India – 133001
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Ace Medipharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Ace Medipharma Private Limited
The main business activity of Ace Medipharma is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ace Medipharma Private Limited FY 2025 filings available
Ace Medipharma Private Limited reported revenue of ₹2.17 Cr (up 4% YoY) for FY 2024.
Revenue · FY 2024
₹2.17 Cr ▲ 4%
Net profit · FY 2024
₹68,890 margin 0.3%
EBITDA · FY 2024
₹3.37 Lakh margin 1.6%
Compounded Annual Growth Rate (CAGR) of Ace Medipharma Private Limited
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 2%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 68%
3 years · compounded
▲ 23%
5 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 4% growth in the latest year. EBITDA rose 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ace Medipharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.37 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹68,890 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ace Medipharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ace Medipharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Ace Medipharma Private Limited
Ace Medipharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narender Pal Singh Also directs: Medomak Healthcare LLP, Belcourt Pharma Private Limited | Director | 11 May 2009 | 17 Years 5 Months | Current |
| Paramjot Singh Also directs: Medomak Healthcare LLP, Belcourt Pharma Private Limited | Director | 12 Dec 2014 | 11 Years 10 Months | Current |
Peer Comparison of Ace Medipharma Private Limited
Ace Medipharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mefro Pharmaceuticals Pvt Ltd | ₹2.17 Cr (FY 2025) | •••• | •••• | 1341.0% | •••• | Punjab, India |
| Abgy International Private Limited | ₹2.17 Cr (FY 2024) | •••• | •••• | 223.0% | •••• | New Delhi, Delhi, India |
| Aryan Medicity Private Limited | ₹2.17 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Godda, Jharkhand, India |
| Adore Lifescience Private Limited | ₹2.17 Cr (FY 2024) | •••• | •••• | -23.0% | •••• | Baddi, Himachal Pradesh, India |
| Proteon Pharmaceuticals India Private Limited | ₹2.17 Cr (FY 2024) | •••• | •••• | -11.0% | •••• | Thane, Maharashtra, India |
| Ace Medipharma Private Limited this company | ₹2.17 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Ambala Cantt, Haryana, India |
| Jiwadaya Healthcare Private Limited | ₹2.17 Cr (FY 2025) | •••• | •••• | -15.0% | •••• | Mumbai, Maharashtra, India |
| Saanvi Pharmachem Private Limited | ₹2.16 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Moradabad, Uttar Pradesh, India |
| Be-Line Pharmaceuticals Private Limited | ₹2.16 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Thanjavur, Tamil Nadu, India |
| Roulex Laboratories Private Limited | ₹2.15 Cr (FY 2025) | •••• | •••• | 50.0% | •••• | Ernakulam, Kerala, India |
| 5E Technologies Private Limited | ₹2.15 Cr (FY 2024) | •••• | •••• | -84.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Ace Medipharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ace Medipharma Private Limited
Ace Medipharma Private Limited is audited by GANDHI MINOCHA & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GANDHI MINOCHA & CO | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Ace Medipharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ace Medipharma Private Limited
Open charges
₹40 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Apr 2025 | Yes Bank Limited | ₹40 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Ace Medipharma Private Limited
Employment history and EPFO contributions of people linked to Ace Medipharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ace Medipharma Private Limited
Ace Medipharma Private Limited has 3 board changes on record since 2009: 2 appointments and 1 cessation. The latest: Gaurav Gulati ceased to be Director on 20 Dec 2014.
AGM
Ace Medipharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Yes Bank Limited amounted to Rs. 40.00 Lakh with Charge ID 101149888 was registered on 25 Apr 2025.
Filing
Ace Medipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Ceased
Gaurav Gulati ceased to be Director.
Appointed
Paramjot Singh was appointed as Director.
Appointed
Narender Pal Singh was appointed as Director.
Incorporation
11 May 2009
Ace Medipharma Private Limited was registered on 11 May 2009 with Roc Haryana & aged 17 years 5 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Ace Medipharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ace Medipharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ace Medipharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ace Medipharma Private Limited
Ace Medipharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAHCA7582R1Z1 | Punjab | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ace Medipharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ace Medipharma Private Limited
Ace Medipharma is an active private limited company based in Ambala Cantt, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 May 2009 (17+ years old) and is registered under CIN U24296HR2009PTC039075.
Ace Medipharma reported revenue of ₹2.17 Cr for FY 2024 (up 4% YoY).
Ace Medipharma has 2 current directors:
- Narender Pal Singh - Director
- Paramjot Singh - Director
Ace Medipharma reported a net profit of ₹68,890 (net margin 0.3%) and EBITDA of ₹3.37 Lakh (EBITDA margin 1.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ace Medipharma is 2% over three years and 6% over five years. In the latest year (FY 2024) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ace Medipharma is 03AAHCA7582R1Z1, registered in Punjab.
The CIN (Corporate Identification Number) of Ace Medipharma is U24296HR2009PTC039075. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ace Medipharma was incorporated on 11 May 2009, making it 17+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Ace Medipharma by revenue are Mefro Pharmaceuticals Pvt Ltd, Abgy International Private Limited, Aryan Medicity Private Limited, Adore Lifescience Private Limited, Proteon Pharmaceuticals India Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Gaurav Gulati ceased to be Director on 20 Dec 2014. Paramjot Singh was appointed as Director on 12 Dec 2014. Narender Pal Singh was appointed as Director on 11 May 2009.
Yes, Ace Medipharma is registered as a micro enterprise under Udyam registration (number: UDYAM-PB-20-0038188).